About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
R & D - Skill Enhancement
  > R & D
  Overview
  Principal Domains
  Skill Base
  Publications
  Highlights
  Discovery Pipeline
  Intellectual Property
  Active Discovery Programs
 
 
     
 

Publications

2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005


2012

 Title  EGFR targeting monoclonal antibody
 combines with an mTOR inhibitor and  potentiates tumor inhibition by acting on  complementary signaling hubs.
 Authors  Roshan James, Siddharth Vishwakarma,  Indira V. Chivukula, Chetana Basavaraj,  Ramakrishnan Melarkode, Enrique Montero  and Pradip Nair
 Journal  Cancer Medicine 2012;1:114-27.


 Title  A novel one-pot de-blocking and conjugation
 reaction step leads to process intensification
 in the manufacture of PEGylated insulin
 IN-105
 Authors  Partha Hazra, Amarnath Chatterjee Qais
 Shabandri, Laxmi Adhikary, Nitesh Dave,
 Madhavan Buddha
 Journal  Bioprocess Biosyst Eng, 2012, 35:1333–1341


 Title  Are Clones Really Unstable?
 Authors  Kriti Shukla, Saravanan Desan, Ankur
 Bhatnagar, Anuj Goel
 Journal  ESACT Proceedings Volume 5, 2012,
 pp 13-18


 Title  Manipulation of a Perfusion Process by
 Medium Optimization
 Authors  Saravanan Desan, Omkar Nandi, Ankur
 Bhatnagar, Anuj Goel
 Journal  ESACT Proceedings Volume 5, 2012,
 pp 335-340
 
     
Skill Enhancement
 
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2018, Biocon. All Rights Reserved